Gemina Laboratories' market value is the price at which a share of Gemina Laboratories trades on a public exchange. It measures the collective expectations of Gemina Laboratories investors about its performance. Gemina Laboratories is trading at 0.05 as of the 9th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.05. With this module, you can estimate the performance of a buy and hold strategy of Gemina Laboratories and determine expected loss or profit from investing in Gemina Laboratories over a given investment horizon. Check out Gemina Laboratories Correlation, Gemina Laboratories Volatility and Gemina Laboratories Performance module to complement your research on Gemina Laboratories.
Please note, there is a significant difference between Gemina Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gemina Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gemina Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Gemina Laboratories 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gemina Laboratories' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gemina Laboratories.
0.00
11/11/2025
No Change 0.00
0.0
In 3 months and 1 day
02/09/2026
0.00
If you would invest 0.00 in Gemina Laboratories on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Gemina Laboratories or generate 0.0% return on investment in Gemina Laboratories over 90 days. Gemina Laboratories is related to or competes with Rocket Pharmaceuticals, Aura Biosciences, Annexon, Solid Biosciences, Larimar Therapeutics, Altimmune, and Autolus Therapeutics. Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vit... More
Gemina Laboratories Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gemina Laboratories' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gemina Laboratories upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gemina Laboratories' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gemina Laboratories' standard deviation. In reality, there are many statistical measures that can use Gemina Laboratories historical prices to predict the future Gemina Laboratories' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Gemina Laboratories. Your research has to be compared to or analyzed against Gemina Laboratories' peers to derive any actionable benefits. When done correctly, Gemina Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Gemina Laboratories.
Gemina Laboratories February 9, 2026 Technical Indicators
Gemina Laboratories holds Efficiency (Sharpe) Ratio of -0.0776, which attests that the entity had a -0.0776 % return per unit of risk over the last 3 months. Gemina Laboratories exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gemina Laboratories' Standard Deviation of 18.32, risk adjusted performance of (0.05), and Market Risk Adjusted Performance of 0.8581 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -1.65, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Gemina Laboratories are expected to decrease by larger amounts. On the other hand, during market turmoil, Gemina Laboratories is expected to outperform it. At this point, Gemina Laboratories has a negative expected return of -1.45%. Please make sure to check out Gemina Laboratories' jensen alpha and the relationship between the value at risk and day median price , to decide if Gemina Laboratories performance from the past will be repeated at some point in the near future.
Auto-correlation
0.25
Poor predictability
Gemina Laboratories has poor predictability. Overlapping area represents the amount of predictability between Gemina Laboratories time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gemina Laboratories price movement. The serial correlation of 0.25 indicates that over 25.0% of current Gemina Laboratories price fluctuation can be explain by its past prices.
Other Information on Investing in Gemina Pink Sheet
Gemina Laboratories financial ratios help investors to determine whether Gemina Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gemina with respect to the benefits of owning Gemina Laboratories security.